KOHJIN BIO CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,533 JPY | +0.46% |
|
-8.70% | 0.00% |
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2022 | 2023 |
|---|---|---|
| Net sales 1 | 3,947 | 4,742 |
| EBITDA | - | - |
| EBIT 1 | 971 | 1,268 |
| Operating Margin | 24.6% | 26.74% |
| Earnings before Tax (EBT) 1 | 922 | 1,243 |
| Net income 1 | 587 | 829 |
| Net margin | 14.87% | 17.48% |
| EPS 2 | 173.3 | 199.0 |
| Free Cash Flow | - | - |
| FCF margin | - | - |
| FCF Conversion (EBITDA) | - | - |
| FCF Conversion (Net income) | - | - |
| Dividend per Share | - | - |
| Announcement Date | 3/22/24 | 3/22/24 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2022 | 2023 |
|---|---|---|
| Net Debt 1 | 493 | 636 |
| Net Cash position 1 | - | - |
| Leverage (Debt/EBITDA) | - | - |
| Free Cash Flow | - | - |
| ROE (net income / shareholders' equity) | - | 31.7% |
| ROA (Net income/ Total Assets) | - | 13.5% |
| Assets 1 | - | 6,135 |
| Book Value Per Share 2 | 654.0 | 724.0 |
| Cash Flow per Share 2 | 512.0 | 351.0 |
| Capex | - | - |
| Capex / Sales | - | - |
| Announcement Date | 3/22/24 | 3/22/24 |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 49.23M | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
- Stock Market
- Equities
- 177A Stock
- Financials Kohjin Bio Co., Ltd.